The University of Alabama at Birmingham (UAB) has received a five-year, $12 million contract from the National Institute of Allergy and Infectious Diseases to study genetic factors that influence how well individuals respond to the anthrax vaccine.
This research will provide valuable information about individual differences in immune response and in adverse reactions to the anthrax vaccine, says Richard Kaslow, MD, professor of epidemiology in the School of Public Health at UAB.
The investigation will rely heavily on information gathered from an ongoing study of the anthrax vaccine under way at several medical research institutions, including UAB.
Hopefully, our work will give us greater insight into the way the vaccine works and the role of genetics in determining response, Kaslow adds.
Source: University of Alabama at Birmingham
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Is the US Quietly Ending COVID-19 Vaccination for the Young and Healthy
July 29th 2025As the FDA limits COVID-19 vaccine approvals to high-risk groups, healthy adults and pregnant individuals are being left behind. Learn how these changes could impact insurance coverage, long COVID prevention, and public health strategies.
Sharps Safety Starts with Us: Why Infection Preventionists Must Lead the Charge
July 28th 2025Sharps injuries remain a silent but serious threat in health care that infection preventionists are uniquely equipped to confront. With underreporting widespread and safety devices underused, it’s time for IPs to step into a leadership role, using their expertise in systems thinking, education, and policy to build a culture where staff protection is as prioritized as patient care.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.